The Nanobioengineering Laboratory Leads The Nanometric Scale Research Of A European Project Focused On The Differentiation Of Stem CellsJuly 23, 2004The director of the Nanobioengineering Laboratory of the CREBEC and sub-director of the Parc Cient'fic de Barcelona (PCB, Barcelona Science Park), Josep Samitier, will coordinate the research lines on the application of nanobiotechnologies for the differentiation of stem cells in the European project entitled CellPROM, the most funded project in the first call of the VI Framework Programme. Josep Samitier will preside the CellPROM Scientific Committee on Nanotechnologies and will join its Management Committee, together with the coordinator of basic research, Andreas Manz, and the coordinator of CellPROM, Gunter Führ, from the Fraunhofer Institut Biomedizinische Technik. In addition, the Nanobioengineering Laboratory also coordinates the broadest line of research in the project, accounting for 34% of the scientific effort, which focuses on the development of artificial surfaces that allow the controlled differentiation of stem cells whilst simultaneously minimizing their rejection once implanted in the patient. The project is based on the premise that stem cells can be differentiated through interactions that take place at the cell surface. The final objective of CellPROM is to develop technologies with therapeutic applications in the field of the so-called tissue engineering by applying the tools provided by nanotechnology and the know-how on the differentiation of adult stem cells. Specifically, by producing cell cultures and tissues that can be used for auto-transplants, the project will allow Europe to lead the development in the new medical technology required to use stem cells for regenerative therapies. At present, regenerative therapies are underway that, for example, use bone marrow-derived adult stem cells cultured in the laboratory, which are then implanted. CellPROM will develop surfaces that mimic biological ones, on which stem cells can be cultured through molecular signals that facilitate a more precise differentiation into the cells of interest. Furthermore, the resulting cell cultures can also be used as alternatives to assays that involve experimental animals. These advances will have practical applications in the fields of new medical technology and in the biotechnology, pharmaceutical and agroalimentary sectors. The final outcome of CellPROM will be a prototype that cannot be used in humans until it has passed the clinical trial phases, which will be started shortly. The CellPROM project has a total budget of more than 26 million Euros, 17.6 million of which have been granted by the European Commission. The project was officially presented in Saarbrücken, Germany, on 25 and 26 March 2004. | |||||||||||||||||||||
|
Related Stem Cells News Articles TAU Researchers Create New Stem Cell Screening Tool Stem cell research is the next great leap in medicine. In the future, new tissue grown in a laboratory could replace a failing heart, or new cells take the place of damaged cells in the brain. NC State Is First University in Nation to Offer Canine Bone Marrow Transplants Dogs suffering from lymphoma will be able to receive the same type of medical treatment as their human counterparts, as North Carolina State University becomes the first university in the nation to offer canine bone marrow transplants in a clinical setting. Hearing restoration may be possible with cochlear repair after transplant of human cord blood cells According to an Italian research team publishing their findings in the current issue of Cell Transplantation (17:6), hearing loss due to cochlear damage may be repaired by transplantation of human umbilical cord hematopoietic stem cells (HSC) since they show that a small number migrated to the damaged cochlea and repaired sensory hair cells and neurons. Cardiac cell transplant studies show promise in cardiac tissue repair Two studies published in the current issue of CELL TRANSPLANTATION (17:6) examine the efficacy of transplanting bone marrow cells (BMCs) for the repair of heart tissue. Stem cell research puts interstate rivalry on hold Victoria and New South Wales have put aside their competitive interstate rivalry to collaborate on a stem cell research project, as announced by Innovation Minister Gavin Jennings and NSW Minister for Science and Medical Research, Verity Firth, today. Blood vessel cells are instructed to form tube-like structures How do blood vessel cells understand that they should organise themselves in tubes and not in layers? A research group from Uppsala University shows for the first time that a special type of "instructor" molecule is needed to accomplish this. These findings, published in the scientific journal Blood, might be an important step towards using stem cells to build new organs. Antidepressants need new nerve cells to be effective, researchers find Researchers at UT Southwestern Medical Center have discovered in mice that the brain must create new nerve cells for either exercise or antidepressants to reduce depression-like behavior. Antidepressants need new nerve cells to be effective, UT Southwestern researchers find Researchers at UT Southwestern Medical Center have discovered in mice that the brain must create new nerve cells for either exercise or antidepressants to reduce depression-like behavior. Alcohol consumption can cause too much cell death, fetal abnormalities The initial signs of fetal alcohol syndrome are slight but classic: facial malformations such as a flat and high upper lip, small eye openings and a short nose. Carnegie Mellon MRI technology that non-invasively locates, quantifies specific cells in the body Magnetic resonance imaging (MRI) isn't just for capturing detailed images of the body's anatomy. Thanks to novel imaging reagents and technology developed by Carnegie Mellon University scientist Eric Ahrens, MRI can be used to visualize - with "exquisite" specificity - cell populations of interest in the living body. More Stem Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||